Vol , Issue Date of Publication: October 01, 2013
DOI: https://doi.org/10.20529/IJME.2013.077

Views
, PDF Downloads:

Ethical issues in adapting new technologies for rapid diagnosis

Richard A Cash
Abstract:

The Xpert® MTB/RIF (hereafter Xpert) is a recent technology that has "demonstrated sensitive detection of tuberculosis (TB) and rifampicin resistance directly from untreated sputum in less than two hours" . Many are in favour of the widespread implementation of this technology in India. In a recent article in the IJME, Singh, Bhan and Upshur state that "India is ethically obliged to phase in the nationwide deployment of Xpert...as soon as reasonably possible" and "is ethically obliged to provide those diagnosed with first-line drug resistance universal access to second-line TB drugs" to treat multiple drug-resistant tuberculosis (MDR-TB) .


Copyright and license
©Indian Journal of Medical Ethics 2016: Open Access and Distributed under the Creative Commons license ( CC BY-NC-ND 4.0),
which permits only non-commercial and non-modified sharing in any medium, provided the original author(s) and source are credited.

Full Text

HTML | PDF
Help IJME keep its content free. You can support us from as little as Rs. 500 Make a Donation